Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...

A new study reveals that the brain’s vulnerability to disorders like multiple sclerosis and dementia may begin in early life.

Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...

The MIND diet significantly reduces disability and fatigue, improving quality of life for people with MS, a long-term study ...

People with MS experience significant changes in cognition more than a year before significant physical decline is evident, a ...

Elevated vitamin D levels may lower the risk for MS in White individuals, though this association is less pronounced in Black individuals.

Until now, Multiple Sclerosis has been a disease that has baffled scientists and doctors. New research, however, is pointing to a surprising potential cause of Multiple Sclerosis (MS): two specific ...

Major revisions to the diagnostic criteria for neuromyelitis optica spectrum disorder will broaden their scope to related syndromes and have a substantial clinical impact.

Researchers say a drug already used to help people with multiple sclerosis walk better could speed up how bones repair themselves.

A new trial assessing the ability of COYA 302 to slow the progression of ALS will enroll up to 120 patients at sites in the U ...

New research presented today at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...

New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...